Astrana Health Q1 2024 GAAP EPS $0.31 Beats $0.30 Estimate, Sales $404.356M Miss $413.849M Estimate
Portfolio Pulse from Benzinga Newsdesk
Astrana Health (NASDAQ:ASTH) reported Q1 2024 earnings of $0.31 per share, exceeding estimates by 3.33% and marking a 10.71% increase from the previous year. However, their sales of $404.356M fell short of expectations by 2.29%, despite being a 19.90% increase from the previous year.
May 07, 2024 | 8:55 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Astrana Health reported a Q1 2024 EPS of $0.31, surpassing estimates, with a 10.71% YOY increase. Sales reached $404.356M, missing estimates but growing 19.90% YOY.
While Astrana Health's EPS beat estimates and showed significant year-over-year growth, the miss on sales estimates could temper investor enthusiasm, leading to a neutral short-term impact on the stock price. The EPS beat indicates operational efficiency and profitability, which is positive, but the sales miss may raise concerns about growth sustainability.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100